Vivo Bio tech Ltd. — Major Shareholding Notification 2026

Jan 9, 2026

January 08, 2026

To, To, BSE Ltd Vivo Bio Tech Limited PJ Towers, 03[rd] Floor, Ilyas Mohammed Khan Estate, #8-2-672/5 Dalal Street, & 6, Road No.1, Banjara Hills, ,Hyderabad, Hyderabad, Mumbai – 400001. Telangana, India, 500034 BSE Scrip Code: 511509

Dear Sir/Madam,

Sub: - Reporting under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011

With reference to the above, please find enclosed reporting under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeover) Regulations, 2011 pursuant to the allotment of 90,000 Equity Shares on preferential basis in Vivo Bio Tech Limited on January 06, 2026.

This is for your information and records.

Thanking you

Yours Truly

==> picture [131 x 54] intentionally omitted <==

Kompella Lopa Mudra Promoter Group

Disclosures under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011

Name of the Target Company (TC)	Name of the Target Company (TC)	Name of the Target Company (TC)	VIVO BIO TECH LIMITED	VIVO BIO TECH LIMITED
Name(s) of the acquirer and Persons Acting in Concert(PAC)with the acquirer			Kompella Lopa Mudra
Whether the acquirer belongs to Promoter/Promotergroup			Promoter Group
Name(s) of the Stock Exchange(s) where the shares of TC are Listed			BSE Limited
Details of the acquisition / follows		~~disposal~~as	Number	% w.r.t.total share/voting capital wherever applicable(*)	% w.r.t. total diluted share/voting capital of the TC ()**
Before the acquisition /~~sale~~under consideration, holding of : a) Shares carrying voting rights b) Shares in the nature of encumbrance (pledge/~~lien/ non-~~ ~~disposal undertaking/ others~~ c) Voting rights (VR) otherwise than by shares d) Warrants/convertible securities/any other instrument that entitles the acquirer to receive shares carrying voting rights in the T C (specify holding in each category) e) Total(a+b+c+d)			2,43,333 - - 4,40,000 6,83,333	1.10 - - 1.99 3.09	1.03 - - 1.86 2.89
Details a) b) c) d)	of acquisition/~~sale~~ Shares carrying voting rights acquired/sold VRs acquired /sold otherwise than by shares Warrants/convertible securities/any other instrument that entitles the acquirer to receive shares carrying voting rights in the TC (specify holding in each category) acquired/sold Shares encumbered/pledged/		90,000 - (90,000) -	0.40 - (0.40) -	0.38 - (0.38) -

	invoked/released by the acquirer e) Total(a+b+c+/-d)	-	-	-
	After the acquisition /~~sale~~, holding of: a) Shares carrying voting rights b) Shares encumbered with the acquirer c) VRs otherwise than by shares d) Warrants/convertible securities/any other instrument that entitles the acquirer to receive shares carrying voting rights in the TC (specify holding in each category) after acquisition e) Total(a+b+c+d)	3,33,000 - - 3,50,000 6,83,333	1.50 - - 1.58 3.09	1.41 - - 1.48 2.89
	Mode of acquisition / ~~market / off-market /~~	Allotment of equity shares pursuant to conversion of warrants issued on preferential basis
	date of receipt of intimation of allotment of shares, whichever is applicable	January 06, 2026
	Equity share capital / total voting capital of the TC before the said acquisition/ ~~sale~~	2,21,00,628 Equity shares of Rs. 10 each aggregatingRs. 22,10,06,280/-
	Equity share capital/ total voting capital of the TC after the said acquisition/ ~~sale~~	2,21,90,628 Equity shares of Rs. 10 each aggregatingRs. 22,19,06,280/-
	Total diluted share/voting capital of the TC after the said acquisition/ ~~sale~~	2,36,28,520 Equity shares of Rs. 10 each aggregatingRs. 23,62,85,200/-**
	Diluted Share Capital:

**The above Equity share capital is based on the assumption that outstanding Warrants 14,37,892 shall be converted into equity shares, in one or more tranches).

==> picture [131 x 54] intentionally omitted <==

Kompella Lopa Mudra Promoter Group

Place: Hyderabad Date: January 08, 2026